Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100

New Scientific Publications

Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
2 NEW Week of April 11, 2021
Remodeling the tumor microenvironment for improved CAR T-cell therapy

Remodeling the tumor microenvironment for improved CAR T-cell therapy

From the Riddell and Srivastava Labs, Clinical Research Division
Science Spotlight - February 15, 2021
Fred Hutch statement regarding the FDA approval of CD19 immunotherapy, lisocabtagene maraleucel

Fred Hutch statement regarding the FDA approval of CD19 immunotherapy, lisocabtagene maraleucel

The newly-approved CAR T-cell therapy was developed in part by Fred Hutch physician-scientists
News Releases - February 05, 2021
What’s new in breast cancer research? SABCS20 goes virtual

What’s new in breast cancer research? SABCS20 goes virtual

Hutch scientists share findings on treatment, imaging, CAR T therapy, COVID-19’s impact on cancer patients and more
Hutch News - December 18, 2020
Scientists show thin metal mesh loaded with T cells shrinks solid tumors

Scientists show thin metal mesh loaded with T cells shrinks solid tumors

Within weeks, CAR T cells targeting ovarian cancer cleared tumors in 70% of treated mice, shows study in Nature Biomedical Engineering. (Note: Images available for media use.)
News Releases - December 09, 2019
Cancer immunotherapy gets assist from micro-scale engineering

Cancer immunotherapy gets assist from micro-scale engineering

With new molecular 'handles' and stimulating signals, metallic thin films become a stronghold for cancer-killing immune cells
Hutch News - December 09, 2019
Try, try again: Can a 2nd dose of CAR T cells succeed when the first fails?

Try, try again: Can a 2nd dose of CAR T cells succeed when the first fails?

First-of-its-kind study offers early indication of factors linked to increased odds of success for patients out of options
Hutch News - December 07, 2019
Last Modified, April 02, 2020